feed,title,long_url,short_url
Investors,Palantir Stock Wins Mizuho Rating Upgrade To Neutral But Valuation Still An Issue,https://www.investors.com/news/technology/palantir-stock-upgrade-neutral-mizuho-valuation/,
Investors,"Donald Trump Is Finally Making Good On Pharma Tariffs Threats, But Stocks Yawn",https://www.investors.com/news/technology/pharmaceutical-tariffs-august-2025-drug-stocks/,
